Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions
Abstract Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a wide variety of diseases, and recent results have been promising. This review summarizes the current status...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2023-12-01
|
| Series: | iRADIOLOGY |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/ird3.46 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|